[HTML][HTML] Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits

Y Jiang, Q Yuan, W Lv, S Xi, W Huang, Z Sun… - Theranostics, 2018 - ncbi.nlm.nih.gov
We aimed to evaluate whether radiomic feature-based fluorine 18 (18 F) fluorodeoxyglucose
(FDG) positron emission tomography (PET) imaging signatures allow prediction of gastric …

[HTML][HTML] Snail enhances glycolysis in the epithelial-mesenchymal transition process by targeting FBP1 in gastric cancer

J Yu, J Li, Y Chen, W Cao, Y Lu, J Yang… - Cellular Physiology and …, 2017 - karger.com
Background: Snail is a key regulator of epithelial-mesenchymal transition (EMT) in cancer.
However, the regulatory role and underlying mechanisms of Snail in gastric cancer …

The role of [18F] FDG PET/CT for gastric cancer management

E Salmanoglu - Nuclear Medicine Review, 2021 - journals.viamedica.pl
Gastric cancer (GC) is a common cause of cancer-related deaths in the world. In addition to
the patient's clinical history and clinical examination, nuclear medicine tools are required for …

Evaluation of fluorine-18-fluorodeoxyglucose PET/computed tomography and human epithelial growth factor receptor 2 expression in treatment-naive patients with …

Y Li, X Wu, J Fang, Q Zhao, Y Huang… - Nuclear Medicine …, 2022 - journals.lww.com
Objective Human epithelial growth factor receptor 2 (HER2) is overexpressed in several
types of cancers. The correlation between tumor glucose activity and HER2 expression can …

[HTML][HTML] A 18FDG PET/CT-based volume parameter is a predictor of overall survival in patients with local advanced gastric cancer

J Song, Z Li, P Chen, J Yu, F Wang… - Chinese Journal of …, 2019 - ncbi.nlm.nih.gov
Objective The present study investigated the prognosis value of preoperative
fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) …

[HTML][HTML] The Relationship Between HER-2 Expression Levels and 18F-FDG PET/CT Parameters in Gastric Cancer

SA Ertürk, Z Hasbek, H Özer - Molecular Imaging and …, 2021 - ncbi.nlm.nih.gov
Objectives: Human epidermal growth factor receptor-2 (HER-2) is a protooncogene encoded
by ERBB2 on chromosome 17. 18 Fluoridefluorodeoxyglucose positron emission …

[HTML][HTML] The correlation between molecular pathological profiles and metabolic parameters of 18F-FDG PET/CT in patients with gastroesophageal junction cancer

J Song, Z Li, P Chen, N Zhou, Y Zhang, Z Yang… - Abdominal …, 2020 - Springer
Objective The aim of this study was to evaluate PET/FDG metabolic parameters in locally
advanced GEJC and correlate it with molecular pathological profiles. Methods We …

The Relationship Between HER2 Status Acquired From Pathological Data and Metabolic Parameters From Pre-treatment 18F-FDG PET/CT in Gastric …

MNA Tayyar, MÖ Tamam, GB Babacan, MC Şahin… - 2023 - researchsquare.com
Aim This study aimed to investigate the relationship between pathological data with strong
importance to Human Epidermal Growth Factor Receptor 2 (HER2) status, and pre-treatment …

Correlation between endoscopic findings and pathologic eternitis in gastric cardia ulcer: a 308 cases analysis

C Qianqian, W Peng, Z Xiuli… - … OF CHINESE PLA …, 2017 - xuebao.301hospital.com.cn
Objective To investigate the correlation between endoscopic findings and pathologic
features of gastric cardia ulcer. Methods A retrospective analysis of the endoscopic and …

[HTML][HTML] 胃癌人表皮生长因子受体 2 影像学进展

张舒畅, 温生宝 - Advances in Clinical Medicine, 2022 - hanspub.org
胃癌是全球第五大常见癌症和第四大癌症死亡原因. 研究表明, 曲妥珠单抗联合标准化疗可显著
提高HER-2 阳性晚期疾病的总体生存率. 近年来, 随着影像技术的发展和广泛应用 …